Role of lipid-lowering agents in the management of diabetic retinopathy

doi:10.4239/wjd.v8.i1.1

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8116)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

628

WORD

283

HTML

4299

Figures (1-1)

277

Tables (1-1)

244

Sum=5731

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1019

Download

1366

Sum=2385

Jan 15, 2017 (publication date) through Jan 26, 2025

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Diabetes. Jan 15, 2017; 8(1): 1-6
Published online Jan 15, 2017. doi: 10.4239/wjd.v8.i1.1

Open in New Tab Full Size Figure Download Figure

Figure 1 The most important pathogenetic mechanisms involved in the development of diabetic retinopathy.

Citation: Ioannidou E, Tseriotis VS, Tziomalos K. Role of lipid-lowering agents in the management of diabetic retinopathy. World J Diabetes 2017; 8(1): 1-6
URL: https://www.wjgnet.com/1948-9358/full/v8/i1/1.htm
DOI: https://dx.doi.org/10.4239/wjd.v8.i1.1